Avgerinos I, Michailidis T, Liakos A, Karagiannis T, Matthews DR, Tsapas A, Bekiari E
This means: They haven't gone through the same rigorous testing for safety and how well they work
Category 3: Bulk Drug Substances lacking sufficient documentation or evidence for the FDA to evaluate them and cannot be compounded as active ingredients
For weekly GLP-1 medications such as semaglutide (Ozempic, Wegovy) and dulaglutide (Trulicity), timing is less critical due to their extended half-lives and sustained therapeutic effects
Why Are Athletes Exploring Peptide Therapy Alongside IV Therapy
These findings suggest that GLP-1 weight loss is influencing aesthetic consultation patterns beyond fat reduction alone